Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor κB

Gynecologic Oncology

Volumn 114, Issue 3, 2009, Pages 509-515

  Oh, Jeong Hyun ^a   Kim, Ji Hye ^a   Ahn, Hak Jun ^a   Yoon, Jong Hyuck ^a   Yoo, Seung Chul ^a   Choi, Dong Soon ^b   Lee, In Seon ^c   Ryu, Hee Sug ^a   Min, Churl K ^a  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Keimyung University   (South Korea)

Author keywords

Endometrial cancer; Invasion; MMP 9; NF B transactivation; Syndecan 1

Indexed keywords

BETA5 INTEGRIN; CD51 ANTIGEN; FOCAL ADHESION KINASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LIGAND; LIPOFECTAMINE; PROTEIN KINASE B; PROTEOGLYCAN; SYNDECAN 1; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME PHOSPHORYLATION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR PROMOTION; UPREGULATION;

ADENOCARCINOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, VITRONECTIN; SYNDECAN-1; TRANSCRIPTIONAL ACTIVATION;

EID: 67651154122     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.027     Document Type: Article

References (40)

1. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68 (1999) 729-777
2. Carey D.J. Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 327 (1997) 1-16
3. Liebersbach B.F., and Sanderson R.D. Expression of syndecan-1 inhibits cell invasion into type I collagen. J. Biol. Chem. 269 (1994) 20013-20019
4. Barbareschi M., Maisonneuve P., Aldovini D., Cangi M.G., Pecciarini L., Angelo Mauri F., et al. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98 (2003) 474-483
5. Davies E.J., Blackhall F.H., Shanks J.H., David G., McGown A.T., Swindell R., et al. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin. Cancer Res. 10 (2004) 5178-5186
6. Hirabayashi K., Numa F., Suminami Y., Murakami A., Murakami T., and Kato H. Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour. Biol. 19 (1998) 454-463
7. Derksen P.W., Keehnen R.M., Evers L.M., van Oers M.H., Spaargaren M., and Pals S.T. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99 (2002) 1405-1410
8. Mercurio F., and Manning A.M. Multiple signals converging on NF-kappaB. Curr. Opin. Cell. Biol. 11 (1999) 226-232
9. Dolcet X., Llobet D., Pallares J., and Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows. Arch. 446 (2005) 475-482
10. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
11. Rayet B., and Gelinas C. Aberrant rel/NF-κB genes and activity in human cancer. Oncogene 18 (1999) 6938-6947
12. Chandler N.M., Canete J.J., and Callery M.P. Increased expression of NF-kappa B subunits in human pancreatic cancer cells. J. Surg. Res. 118 (2004) 9-14
13. Marie-Eve St., Veronique G., Sophie P., and Eric A. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB pathway. Mol. Cancer 11 (2004) 3-7
14. Beauvais D.M., and Rapraeger A.C. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp. Cell. Res. 286 (2003) 219-232
15. Brooks P.C., Klemke R.L., Schon S., Lewis J.M., Schwartz M.A., and Cheresh D.A. Insuline-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J. Clin. Invest. 99 (1997) 1390-1398
16. Tonn J.C., Wunderlich S., Kerkau S., Klein C.E., and Roosen K. Invasive behavior of human gliomas is mediated by interindividually different integrin patterns. Anticancer Res. 18 (1998) 2599-2605
17. McQuade K.J., Beauvais D.M., Burbach B.J., and Rapraeger A.C. Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J. Cell. Sci. 119 (2006) 2445-2456
18. Judson P.L., He X., Cance W.G., and Van Le L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinomas. Cancer 86 (1999) 1551-1556
19. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55 (1995) 2752-2755
20. Park H., Han I., Kwon H.J., and Oh E.S. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells. Cancer Res. 65 (2005) 9899-9905
21. Park D.W., Ryu H.S., Choi D.S., Park Y.H., Chang K.H., and Min C.K. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro. Gynecol. Oncol. 82 (2001) 442-449
22. Tai K.Y., Shieh Y.S., Lee C.S., Shiah S.G., and Wu C.W. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1. Oncogene 27 (2008) 4044-4055
23. Bhoopathi P., Chetty C., Kunigal S., Vanamala S.K., Rao J.S., and Lakka S.S. Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of β1-integrin, ERK, and NF-κB. J. Biol. Chem. 283 (2008) 1545-1552
24. Lee S.O., Jeong Y.J., Kim M.H., Kim C.H., and Lee I.S. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-κB-dependent MMP-9 expression. Biochem. Biophys. Res. Commun. 366 (2008) 1019-1024
25. Choi D.S., Kim J.H., Ryu H.S., Kim H.C., Han J.H., Lee J.S., et al. Syndecan-1, a key regulator of cell viability in endometrial cancer. Int. J. Cancer 121 (2007) 741-750
26. Lin C.W., Hou W.C., Shen S.C., Juan S.H., Ko C.H., Wang L.M., et al. Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29 (2008) 1807-1815
27. Lee S.O., Jeong Y.J., Yu M.H., Lee J.W., Hwangbo M.H., Kim C.H., et al. Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 351 (2006) 118-125
28. Altomare D.A., and Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24 (2005) 7455-7464
29. Pommier Y., Sordet O., Antony S., Hayward R.L., and Kohn K.W. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23 (2004) 2934-2949
30. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin Jr. A.S. Akt stimulates the transactivation potential of the Rel/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276 (2001) 18934-18940
31. Nardo L.G., Bartoloni G., Di Mercurio S., and Nardo F. Expression of alpha(v)beta3 and alpha4beta1 integrins throughout the putative window of implantation in a cohort of healthy fertile women. Acta Obstet. Gynecol. Scand. 81 (2002) 753-758
32. Tuckerman E.M., Laird S.M., Prankash A., and Li T.C. Expression of integrins in the endometrium of women with recurrent miscarriage. Fertil. Steril. 86 (2006) 755-757
33. Beauvais D.M., Burbach B.J., and Rapaeger A.C. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell. Biol. 167 (2004) 171-181
34. Hong S., Park K.K., Magae J., Ando K., Lee T.S., Kwon T.K., et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J. Biol. Chem. 280 (2005) 25202-25209
35. Park Y.H., Ryu H.S., Choi D.S., Chang K.H., Park D.W., and Min C.K. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int. J. Gynecol. Cancer 13 (2003) 53-60
36. Baldwin A. The transcription factor NF-κB and human disease. J. Clin. Invest. 107 (2001) 3-6
37. Hess A.R., Postovit L.M., Margatyan N.V., Seftor E.A., Schneider G.B., Sefter R.E.B., et al. Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res. 65 (2005) 9851-9860
38. Lim Y., Park H., Jeon J., Han I., Kim J., Jho E.H., et al. Focal adhesion kinase is negatively regulated by phosphorylation at tyrosine 407. J. Biol. Chem. 282 (2007) 10398-10404
39. Wilcox-Adelman S.A., Denhez F., and Goetinck P. Syndecan-4 modulates focal adhesion kinase phosphorylation. J. Biol. Chem. 277 (2002) 32970-32977
40. Purushothaman A., Chen L., Yang Y., and Sanderson R.D. Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J. Biol. Chem. 283 (2008) 32628-32636